All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the GvHD Hub Steering Committee meeting on April 5, 2022, key opinion leaders met to debate how duration of response should be defined. The recorded discussion was chaired by Mohamad Mohty and featured Amin Alousi, Ali Bazarbachi, Hildegard Greinix, and Attilio Olivieri.
How should duration of response be defined?
Mohty begins by stating that it is only recently, with the approval of agents for GvHD treatment, that the question of how to define response has become a concern. Bazarbachi discusses the importance of achieving an ongoing response rather than a transient one to improve outcomes in acute GvHD. The steering committee contemplate how the side effects of treatment can result in early initiation of the next line of therapy, and the impact of organ damage on response definition is also considered.
Practice-changing abstracts at #ASCO20 and EHA 2020
Interview with GvHD Hub Co-Chair, Mohamad Mohty, providing an overview of the practice-changing abstracts from this year's virtual ASCO Annual Meeting and EHA Annual Congress.
ASH 2019 | Practice-changing abstracts in graft-versus-host disease
The GvHD Hub Steering Committee shared the updated top abstracts from ASH 2019 that they believe could have the greatest impact on clinical practice, in preparation for ASH 2020.
Subscribe to get the best content related to GvHD delivered to your inbox